Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
1.
J Clin Invest ; 48(7): 1177-88, 1969 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-5794244

RESUMEN

Myocardial substrate metabolism was studied in 13 subjects at the time of diagnostic cardiac catheterization by means of palmitic acid-(14)C infusion with arterial and coronary sinus sampling. Two subjects were considered free of cardiac pathology and all, with one exception, demonstrated lactate extraction across the portion of heart under study. Data for this single lactate-producing subject were treated separately.The fractional extraction of (14)C-labeled free fatty acids (FFA) (44.4+/-9.5%) was nearly twice that of unlabeled FFA (23.2+/-7.8%) and raised the possibility of release of FFA into the coronary sinus. FFA uptake, based on either the arterial minus coronary sinus concentration difference or the FFA-(14)C fractional extraction, was directly proportional to the arterial FFA concentration. Gas-liquid chromatography failed to demonstrate selective handling of any individual FFA by the heart. Fractional oxidation of FFA was 53.5+/-12.7%, accounting for 53.2+/-14.4% of the heart's oxygen consumption while nonlipid substrates accounted for an additional 30.0+/-17.3%. Determinations of both labeled and unlabeled triglycerides suggested utilization of this substrate by the fasting human heart. Direct measurement of FFA fractional oxidation as well as FFA uptake, exclusive of possible simultaneous FFA release, would appear necessary in studies concerned with human myocardial FFA metabolism.


Asunto(s)
Ácidos Grasos no Esterificados/metabolismo , Miocardio/metabolismo , Adulto , Anciano , Recolección de Muestras de Sangre , Dióxido de Carbono/sangre , Isótopos de Carbono , Cateterismo Cardíaco , Cromatografía de Gases , Vasos Coronarios , Ayuno , Femenino , Humanos , Masculino , Persona de Mediana Edad , Consumo de Oxígeno , Ácidos Palmíticos/metabolismo , Radioisótopos , Flujo Sanguíneo Regional , Triglicéridos/metabolismo , Xenón
2.
Clin Pharmacol Ther ; 49(3): 322-9, 1991 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-2007326

RESUMEN

Benazepril hydrochloride is a new angiotensin-converting enzyme inhibitor. In a multicenter study, 206 patients with mild to moderate hypertension were randomized to receive benazepril at a dose of 2, 5, 10, or 20 mg, hydrochlorothiazide, 25 mg, or placebo once daily for 4 weeks. The 20 mg dosage of benazepril lowered blood pressure to a degree equal to that of 25 mg hydrochlorothiazide: -12.2/7.7 mm Hg and -13.4/-7.5 mm Hg, respectively. Hydrochlorothiazide proved to be more effective in black subjects. At lower dosage levels of benazepril (2, 5, and 10 mg), blood pressure reduction was not significantly different from that with placebo. In those patients who failed to achieve goal diastolic blood pressure of less than 90 mm Hg with monotherapy after 4 weeks, the addition of open-label hydrochlorothiazide (25 mg/day) to benazepril, hydrochlorothiazide, or placebo produced a substantial additional decrease in blood pressure over a 2-week period. No definite adverse effects on hematologic measurements, serum biochemistry test results, or urinalyses were noted. Subjective adverse experiences were common in all groups but except in three or possibly four instances were not considered causally related to the study drug.


Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Benzazepinas/farmacología , Hipertensión/tratamiento farmacológico , Adulto , Anciano , Inhibidores de la Enzima Convertidora de Angiotensina/administración & dosificación , Inhibidores de la Enzima Convertidora de Angiotensina/efectos adversos , Benzazepinas/administración & dosificación , Benzazepinas/efectos adversos , Población Negra , Presión Sanguínea/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Quimioterapia Combinada , Femenino , Humanos , Hidroclorotiazida/administración & dosificación , Hidroclorotiazida/farmacología , Masculino , Persona de Mediana Edad , Renina/sangre
3.
Am J Cardiol ; 37(4): 467-73, 1976 Mar 31.
Artículo en Inglés | MEDLINE | ID: mdl-1258783

RESUMEN

The myocardial cell requires energy for contractile activity and for the work of internal maintenance. With the onset of ischemia mechanical performance is compromised. If the ischemia is severe and persistent, the energy necessary to maintain the internal millieu proves inadequate and cell death ensues. Ischemic heart disease is a regional phenomenon with normal and abnormal cell metabolism occurring side by side. The ischemic cell demonstrates hemodynamic, electrical and biochemical instability; its passage from a state of reversible to irreversible injury may persist for as long as 7 days and offers an opportunity to introduce interventions that may protect it and reduce ultimate infarct size. There is as yet no adequate objective means for predicting the mass of infarcted tissue. However, studies of regional metabolism, if properly conducted, may help define the adequacy of coronary vascular reserve and characterize the ischemic process. Current techniques utilize a myocardial pacing stress to induce an ischemic response. Although virtually every metabolic pathway is disrupted by severe ischemia, the assay of selected metabolities in arterial and coronary venous blood samples has provided information of diagnostic significance.


Asunto(s)
Enfermedad Coronaria/metabolismo , Vasos Coronarios/metabolismo , Enfermedad Coronaria/diagnóstico , Creatina Quinasa/sangre , Corazón/fisiopatología , Humanos , Lactatos/metabolismo , Infarto del Miocardio/enzimología , Infarto del Miocardio/patología , Miocardio/metabolismo , Marcapaso Artificial , Cintigrafía
4.
Am J Cardiol ; 37(4): 528-32, 1976 Mar 31.
Artículo en Inglés | MEDLINE | ID: mdl-1258790

RESUMEN

There is as yet no adequate animal mode for human myocardial ischemia. The commonly utilized technique of coronary arterial ligation in large animals may induce regional ischemia but introduces variables that make it difficult to compare studies in different laboratories. A model of global ischemia in an isolated perfused rat heart that offers a rapid, inexpensive means for producing graded, controlled, stable state and reproducible ischemia is described. The technique has been utilized with success to study the hemodynamic and metabolic effects of ischemia and to evaluate pharmacologic interventions designed to protect the ischemic myocardium. Propranolol has been shown to improve bioenergetics and reduce anaerobic glycolysis by a depression of the hemodynamic response of ischemic myocardium. Methylprednisolone appears to exert its primary effect by direct coronary vasodilation, increasing resting or control flow and providing an enhanced reserve when ischemia is imposed. Mannitol improves cardiac performance by reducing the increased myocardial cell water content induced by hypoxia or anoxia.


Asunto(s)
Enfermedad Coronaria/tratamiento farmacológico , Modelos Animales de Enfermedad , Manitol/uso terapéutico , Metilprednisolona/uso terapéutico , Infarto del Miocardio/patología , Propranolol/uso terapéutico , Animales , Circulación Coronaria , Enfermedad Coronaria/metabolismo , Corazón/efectos de los fármacos , Hemodinámica/efectos de los fármacos , Lisosomas/efectos de los fármacos , Manitol/farmacología , Metilprednisolona/farmacología , Miocardio/metabolismo , Concentración Osmolar , Perfusión , Propranolol/farmacología , Ratas
5.
Ann Thorac Surg ; 27(1): 42-8, 1979 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-313189

RESUMEN

The present study was performed to evaluate scintigraphic imaging with technetium 99m-labeled glucoheptonate and serum enzyme levels of creatine phosphokinase isoenzyme (MB-CPK) in the early diagnosis of perioperative acute myocardial infarction associated with saphenous vein bypass graft operations. Myocardial imaging was done in 27 patients (50% of whom were considered high-risk) before operation and again 5 hours after operation. Four of these patients (15%) had both electrocardiographic and serum MB-CPK evidence of acute myocardial infarction, and all 4 had developed positive postoperative scintigrams. Four other patients had only elevated serum MB-CPK, and scintigrams became positive after operation in 3 of them. In addition, serum MB-CPK 6 hours after operation was 83 +/- 21 mIU/ml (mean +/- standard error of the mean) in patients with positive postoperative scans compared with 24 +/- 5 mIU/ml in those patients with negative postoperative scintigrams (p less than 0.001). Myocardial imaging with 99mTc-glucoheptonate in the perioperative period is rapid, safe, and atraumatic. Furthermore, our results suggest that it is a sensitive method for the early diagnosis of perioperative acute myocardial infarction, and, when imaging is combined with serum MB-CPK isoenzyme analysis, the reliability of the diagnosis of acute myocardial infarction is enhanced even further. Only 1 of the patients who showed perioperative myocardial damage had acute hemodynamic compromise or obvious impairment of recovery in the immediate postoperative period, and the 30-day mortality of the total group was 4% (1 of 27).


Asunto(s)
Puente de Arteria Coronaria/efectos adversos , Creatina Quinasa/sangre , Corazón/diagnóstico por imagen , Isoenzimas/sangre , Infarto del Miocardio/diagnóstico , Tecnecio , Enfermedad Aguda , Femenino , Heptosas , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/etiología , Periodo Posoperatorio , Cintigrafía , Azúcares Ácidos , Factores de Tiempo
11.
Adv Myocardiol ; 2: 249-57, 1980.
Artículo en Inglés | MEDLINE | ID: mdl-7423042

RESUMEN

Entropy production must accompany the utilization of free energy in any cellular process and is a measure of the degree of randomness or molecular disorder within a system. A highly entropized system approaches equilibrium, is incapable of performing work, and never unrandomizes spontaneously. Therefore, chemical reactions are reversible only if the entropy of the system can be reduced through the expenditure of free energy and at the expense of an increase in the entropy of the surroundings. This concept is discussed in terms of energy production and utilization by myocardial cells under normal and diseased states.


Asunto(s)
Metabolismo Energético , Corazón/fisiología , Contracción Miocárdica , Animales , Corazón/fisiopatología , Humanos , Mamíferos , Miocardio/metabolismo , Termodinámica
12.
Neurol Neurocir Psiquiatr ; 19(4): 230-40, 1978.
Artículo en Español | MEDLINE | ID: mdl-755964

RESUMEN

This study expresses a theory designed to associate the fundamental thermodynamic concepts to the electrophysiology of the nervous system. An analogy is drawn between the thermodynamic and electrical events of the myocardial cell during its mechanical phases with those thermodynamic and electrical events of the nerve cell during conduction. Although the myocardial and nerve cells are designed to perform different functions, their processes of membrane potential activation and corresponding directions of thermodynamic and entropy changes are basically the same. A thermodynamic view of nerve cell "active" potential corresponds to a passive downhill process during which the entropy of the system (nerve cell) increases. In contrast, the so called "resting" membrane potential corresponds to an active uphill process. Thus, there is a paradox because the nerve cell is thermodynamically passive during the "active" membrane potential, whereas it is thermodynamically active during the "resting" membrane potential. It is suggested that inhibition in the nervous system may be considered a thermodinamically active process. If the negentropic process fails, the result is the malfunctioning or the final destruction of the system.


Asunto(s)
Fenómenos Fisiológicos del Sistema Nervioso , Termodinámica , Metabolismo Energético , Corazón/fisiología , Humanos
13.
Artículo en Inglés | MEDLINE | ID: mdl-1215634

RESUMEN

Glycogen is an essential substrate during myocardial anoxia. Since porpranolol may maintain myocardial glycogen levels after acute stress by blockade of catecholamine-induced glycogenolysis, we evaluated the effect of propranolol treatment in the isolated perfused isovolumic paced rat heart. Forty-one rats were studied after 10 min of ice-water immersion: half were pretreated with propranolol, 20 mg/kg/day x3, and half with saline. Glycogen content of unperfused propranolol-treated hearts exceeded controls by 46% (146 +/- 9 vs. 100 +/- 4 mumoles/g dry wt, p less than 0.02), and this difference persisted during aerobic perfusion. Propranolol did not affect adenine nucleotide concentration or left ventricular hemodynamics. Following 5 min of anoxic perfusion, propranolol hearts showed improved ventricular performance concomitant with enhanced glycogenolytic flux and lactate production. Propranolol augmented high energy phosphate production (ATP/AMP = 5.19 +/- 0.42 vs. 3.39 +/- 0.42, p less than 0.02) and increased coronary flow (22.1 +/- 1.6 vs. 16.6 +/- 1.4 ml/min, p less than 0.02) during anoxia. Thus, propranolol supported glycogen stores following acute stresses, enhanced glycogenolytic energy production, increased coronary flow, and improved ventricular function during subsequent anoxia.


Asunto(s)
Glucógeno/metabolismo , Hemodinámica/efectos de los fármacos , Miocardio/metabolismo , Propranolol/farmacología , Animales , Catecolaminas/metabolismo , Circulación Coronaria/efectos de los fármacos , Hipoxia/fisiopatología , Lactatos , Masculino , Perfusión , Fosfatos/metabolismo , Ratas , Agua/metabolismo
14.
J Appl Physiol ; 40(6): 1004-8, 1976 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-931918

RESUMEN

Insertion of a flow pump into the Langendorff retrograde perfusion apparatus has permitted the production of stable, graded ischemia in hearts whose hemodynamic and metabolic response may be evaluated. Ventricular pressures were monitored with a modified balloon and catheter-tip manometer system, and oxygen consumption , lactate and glucose metabolism, and tissue high-energy phosphate stores measured. A 15-min stabilization period in 56 paced hearts was followed by 15 min of either full, 40, 30, 20, or 10% coronary flow, after which the ventricular tissue was freeze-clamped for tissue assay. Tissue creatine phosphate fell progressively from 23.7 in full flow hearts to 9.9 mumol/g dry wt after 90% reduction in flow. This was accompanied by a graded reduction in ATP from 20.3 to 14.0 mumol/g dry wt and a rise in AMP from 1.1 to 2.6 mumol/g dry wt. Tissue lactate rose progressively from 22.3 to 60.1 mumol/g dry wt. Hemodynamic function correlated with coronary flow. This preparation offers an opportunity to study pharmacological and metabolic interventions in ischemic heart disease.


Asunto(s)
Enfermedad Coronaria/metabolismo , Modelos Animales de Enfermedad , Hemodinámica , Miocardio/metabolismo , Adenosina Difosfato/metabolismo , Adenosina Monofosfato/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Circulación Coronaria , Enfermedad Coronaria/fisiopatología , Glucosa/metabolismo , Glucógeno/metabolismo , Técnicas In Vitro , Lactatos/metabolismo , Masculino , Contracción Miocárdica , Consumo de Oxígeno , Fosfocreatina/metabolismo , Ratas
15.
Artículo en Inglés | MEDLINE | ID: mdl-1226456

RESUMEN

Recovery from anoxia has been evaluated in the isovolumic nonrecirculating paced perfused rat heart. Seventy studies were performed consisting of 1) 15 min of aerobic perfusion (AP), 2) AP + 15 min of anoxic perfusion, 3) AP + 15 min of anoxic perfusion + 15 min of reoxygenation. Krebs-Ringer-bicarbonate + 5 mM glucose (KRB) was compared with KRB + mannitol (osmolality, +60 mOsm). Mannitol decreased myocardial water content. It improved recovery of hemodynamic function after reoxygenation. With KRB alone left ventricular systolic peak pressure (LVSp) decreased by 32 percent and maximum dP/dt by 50 percent. With mannitol added LVSp decreased 18 percent and dP/dt 21 percent (p less than 0.01). No effect on energy metabolism was demonstrated. KRB and mannitol did not differentially affect total coronary flow, lactate, and glucose extraction, tissue glycogen, creatine phosphate, or adenine nucleotide concentrations. No significant difference in capillary filling was demonstrated by microfil injection. Mannitol appears to improve LV function by direct myocardial osmotic action unrelated to enhanced energy production.


Asunto(s)
Corazón/fisiopatología , Hipoxia/fisiopatología , Manitol/farmacología , Miocardio/metabolismo , Adenosina Difosfato/metabolismo , Adenosina Monofosfato/metabolismo , Adenosina Trifosfato/metabolismo , Aerobiosis , Animales , Presión Sanguínea/efectos de los fármacos , Agua Corporal/metabolismo , Glucógeno/metabolismo , Corazón/efectos de los fármacos , Hipoxia/metabolismo , Técnicas In Vitro , Concentración Osmolar , Perfusión , Fosfocreatina/metabolismo , Ratas
16.
Am J Physiol ; 229(3): 847-52, 1975 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-1211477

RESUMEN

The mechanism of action of hyperosmolal mannitol was evaluated by hemodynamic and metabolic studies in 79 isovolumic nonrecirculating paced perfused rat hearts during sequential 15-min periods of aerobic, anoxic, and reoxygenated perfusion. Hyperosmolality induced by addition of mannitol significantly decreased myocardial water content (wet/dry wt ratio). It improved recovery of hemodynamic function during reoxygenation. With isomolal perfusion (290 mosmol/kg) left ventricular systolic peak pressure (LVSP) decreased 32% (127 +/- 5 to 86 +/- 6 mmHg) and maximum dP/dt fell 50% (3,513 +/- 328 to 1,758 +/- 172 mmHg/s) during the postanoxic recovery period. With hyperosmolal perfusion (350 mosmol/kg), LVSP decreased 23% (132 +/- 5 to 102 +/- 7 mmHg) and dP/dt fell 21% (3,817 +/- 215 to 2,998 +/- 234 mmHg/s) (P less than .01). Hyperosmolal perfusion did not affect postanoxic total coronary flow, lactate and glucose metabolism, tissue glycogen, creatine phsophate, or adenine nucleotide concentrations. Coronary perfusion with hypersmolal solution aided recovery, enhanced postanoxic myocardial performance, and minimized tissue swelling. The most tenable explanation for the locus of action of hyperosmolal mannitol during anoxia under our experimental conditions is its direct effect on myocardial water content.


Asunto(s)
Corazón/efectos de los fármacos , Hemodinámica/efectos de los fármacos , Hipoxia/metabolismo , Manitol/farmacología , Adenosina Trifosfato/metabolismo , Animales , Circulación Coronaria/efectos de los fármacos , Glucosa/metabolismo , Glucógeno/metabolismo , Corazón/fisiopatología , Hipoxia/fisiopatología , Lactatos/metabolismo , Masculino , Contracción Miocárdica/efectos de los fármacos , Miocardio/metabolismo , Concentración Osmolar , Perfusión , Fosfocreatina/metabolismo , Ratas , Agua/metabolismo
17.
Am J Physiol ; 229(3): 853-60, 1975 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-1211478

RESUMEN

Electron microscopic and microcirculatory effects of hyperosmolal mannitol were evaluated in the isolated perfused isovolumic rat heart. Specimens for ultrastructural examination were obtained in 26 experiemnts after 15 min of sequential aerobic, anoxic, and reoxygenated perfusion using an isosmolal perfusate of Krebs-Ringer-Henseleit bicarbonate buffer (KRB) (osmolality equals 290 mosmol/kg) vs. a hyperosmolal solution of KRB + mannitol (equals 350 mosmol/kg). No significant changes were noted during aerobic perfusion. Anoxic hearts perfused with isosmolal KRB demonstrated the most severe ultrastructural alterations including: mitochondrial swelling with disruption of cristae, myofibrillar fusion and contraction bands, and subsarcolemmal edema and vacuolization. These subcellular changes were not only partially reversed by oxygenated isosmolal perfusion but were significantly reversed during both the anoxic and reoxygenation perfusion periods with mannitol added. Following silicone rubber injection of the microcirculation, only focal capillary endothelial cell swelling was noted, and no difference in arteriolar or capillary filling was observed with either perfusate. Thus, mannitol significantly reversed the postanoxic ultrastructural changes consistently observed in the absence of increased osmolality. No gross effect on vascular patency could be demonstrated.


Asunto(s)
Vasos Coronarios/efectos de los fármacos , Corazón/efectos de los fármacos , Hipoxia/fisiopatología , Manitol/farmacología , Microcirculación/efectos de los fármacos , Miocardio/ultraestructura , Animales , Vasos Coronarios/fisiopatología , Corazón/fisiopatología , Masculino , Manitol/administración & dosificación , Microcirculación/ultraestructura , Concentración Osmolar , Perfusión , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA